rfxcel launches fully integrated Warehouse Edge System with partner Navitas Life Sciences

rfxcel Corporation, the global serialization and track and trace provider for the Life Sciences industry, announced today that its industry-leading traceability system now has fully integrated “edge” functionality for warehouse, distribution and re-work operations (Warehouse Edge System).

rfxcel has extended its successful partnership with Navitas Life Sciences (“Navitas”) to provide a seamless and efficient solution to enable customers to meet obligations under the European Falsified Medicines Directive (EU FMD), US Drug Supply Chain Security Act (DSCSA) and other serialization requirements. The advanced and simple-to-use features of the Navitas traceREADY edge system are now completely integrated with rfxcel’s Traceability System (rTS).

“The new capability provides a truly full-service, one-stop capability for distributors, manufacturers, and the many companies who have a complex hybrid of both operations. Edge and re-work activities during manufacturing and supply can now be handled directly and smoothly in our system. As global regulations increasingly affect distribution as well as manufacture of medicines, we are positioned to offer what customers need” said Glenn Abood, CEO of rfxcel.

“We are pleased to strengthen our successful relationship with rfxcel. Our fully integrated solution now provides customers with significant cost and performance efficiencies. We look forward to taking our solution to the global market and deliver enhanced value to our customers” said Ram Yeleswarapu, President, Navitas Life Sciences.

In the complex world of traceability, rfxcel is refreshingly easy to work with. Transparent pricing and robust private cloud architecture allows customers to get compliant quickly and at predictable cost. They can then focus on their core business without the constant risk assessment and revalidation required by some providers.

Learn more about Serialisation/Serialization and their edge system by booking a 30 min demo with the IT team.

rfxcel Solution Recognized in HDA Distribution Management Award

March 6, 2018 – San Ramon, CA – rfxcel, the world’s leader in supply chain track and trace for the Pharmaceutical industry is one of two companies recognized by the HDA (Healthcare Distribution Alliance) for “…:efforts to improve the efficiency, effectiveness and safety of the healthcare supply chain through successful trading partner initiatives.”

“The award highlights innovative collaborations between distributors and manufacturers that enhance processes, reduce costs and leverage advanced technologies or logistical practices. Recipients are models for leadership and innovation in the pharmaceutical distribution industry and demonstrate the power of successful trading partner relationships .“ HDA Distribution Management Award

rfxcel’s Environmental Monitoring (EM) solution, was awarded Merit Finalist by the HDA for our work to enable real-time visibility of the Pharmaceutical supply chain via IOT (Internet of Things) technology.  The EM solution was piloted with a global manufacturer to track high-value pharmaceutical shipments – delivering real-time location and temperature data across 24 domestic and international locations.

“We at rfxcel are extremely excited about this award from the HDA.  It is recognition not only of our innovation but our commitment to partnering with the HDA and other industry leaders.” said, Glenn Abood, CEO of rfxcel.  

During the pilot, the rfxcel EM solution identified temperature excursions in real-time and alerted the manufacturer to these risks.  This allowed the manufacturer to take immediate action with their logistics provider and protect the integrity of their products. The solution also identified shipments which were improperly delivered to holding locations that were not approved to handle the products.  These improper deliveries were corrected in real-time avoiding potential damage to the high-value products.

“Today, many pharmaceutical companies are focused on meeting near-term serialization and compliance requirements such as Europe’s FMD (Falsified Medicines Directive), United State’s DSCSA (Drug Supply Chain Security Act), and many other governmental requirements. Our EM solution allows companies to extend the value of their compliance and serialization investment to gain new business value that was previously unavailable. Many companies talk about ‘Value Beyond Compliance’ but today, we have demonstrated that we can deliver on this commitment.” said Jack Tarkoff, Chief Strategy Officer of rfxcel.

As the pioneer and leader in traceability solutions for the Life Sciences industry, rfxcel provides its customers with a robust and sophisticated platform with a low total-cost-of-ownership. The EMVO certification – combined with a recent $30M growth capital infusion, the acquisition of Frequentz assets, and important key hires in Europe – widens the Company’s lead as the most versatile player in the industry.

To learn more about the HDA Distribution Management Award, visit:https://www.hda.org/about/industry-recognition/dma

If you would like to receive more details or see a demo of rfxcel’s Environmental Monitoring (EM) solution, please contact us at: https://www.rfxcel.com/contact-rfxcel/

 

For more information contact us:

Herb Wong, VP Marketing

hwong@rfxcel.com

rfxcel.com

 

About rfxcel:

rfxcel is the leading provider of SaaS-based track and trace solutions. Their platform enables companies to protect patients, comply with regulatory mandates, and gain visibility into their supply chain. rfxcel’s relentless commitment to customer success and continuous innovation ensures that companies can meet today’s requirements and tomorrow’s challenges.

To learn more here: Serialization Software

HDA.Award.rfxcel.traceability

DCC Vital selects rfxcel as a serialisation solution provider

Serious About Serialisation: DCC Vital Selects rfxcel as a EU Falsified Medicines Directive and Serialisation Solution Provider

February 21, 2018 – San Ramon, CA, – rfxcel Corporation, a customer-focused serialisation and track and trace provider for the Life Sciences industry, announced today that DCC Vital, a manufacturer headquartered in Dublin, Ireland, has selected rfxcel to meet its European Falsified Medicines Directive (EU FMD) serialisation requirements.

As a European manufacturer of pharmaceuticals and medical devices, and a logistics provider in the UK, DCC Vital prides themselves in their ability to deliver solutions that will make a difference to patient care.   Over the past 5 years, DCC Vital has more than doubled the scale of their business to create a focused support system for their customers in Europe, and most recently have been gaining an increased presence worldwide.  As DCC Vital continues to expand their footprint internationally, the company needed a serialisation platform that could accommodate their diverse product offering, understand the need to keep their customers at the top of their focus, and allow them the flexibility to manage their environment based on their specifications.

“DCC Vital selected rfxcel for 3 reasons,” said Conor O’Shea, DCC Vital’s Head of Information Technology. “First, rfxcel is easy to work with.  Throughout the evaluation process, rfxcel was very responsive and provided clear answers to our questions.  Second, rfxcel offers a simple pricing model that is straight forward & transparent.  Finally, rfxcel offers a customer focused architecture that allows us to manage a validated environment according to our quality standards and schedule.”

Relentless commitment to customer success and continuous innovation ensures that rfxcel’s customers meet their requirements and protect their consumers. “We are seeing a paradigm shift in the industry through recent competitive conversions, due to a lack of personalized attention from vendors.”  said Glenn Abood, CEO of rfxcel.  “Manufacturers and the entire supply chain desire timely response, support, control, and pricing transparency from their solution providers.”

rfxcel offers fixed bid contracts, which ensures customers a clear insight into their pricing model, which is not the case when contracts are based on time and material bids.  “Customers are realizing that compliance with the Falsified Medicines Directive is just the starting point. In digitizing their complex supply chains, they are seeking out partners such as rfxcel who are willing to work with their specific needs and ways of working.  We help customers to succeed, without imposing inflexible processes or the frequent changes, risk assessments and re-validations involved with other vendors,” said Mark Davison, Senior Director of Operations Europe.

To learn more about the requirements surrounding EU Falsified Medicines Directive compliance or how to build a reliable and flexible serialisation platform that suits your needs, please visit our website at EU FMD Overview.

 

For more information contact us:

Herb Wong, VP Marketing

hwong@rfxcel.com

rfxcel.com

 

About rfxcel:

rfxcel is the leading provider of SaaS-based track and trace solutions. Their platform enables companies to protect patients, comply with regulatory mandates, and gain visibility into their supply chain. rfxcel’s relentless commitment to customer success and continuous innovation ensures that companies can meet today’s requirements and tomorrow’s challenges.

To learn more here: Serialization Software

rTS 6.0: New Traceability Solution

rfxcel Traceability System 6.0:  New Traceability Solution Delivers Improved User Experience and Performance

 

San Ramon, February 7, 2018 – rfxcel, the leader in Life Science track and trace, and compliance systems, today announced the release of rfxcel Traceability System (rTS) 6.0.  The new traceability software delivers increased usability and performance which is powered by the new rTS 6.0 architecture and technology stack.

rTS 6.0 is built upon an enhanced architecture that provides greater scalability; allowing new features to be quickly added.  The new product gives users improved visibility into their supply chain via a new, highly responsive user interface (UI) and enhanced report features. Better search capabilities, menu navigation, event relationships, event notifications and alerts, and user configuration options have been added as part of the functional and UI improvements.  rTS 6.0 has been further optimized to deliver up to 3X performance improvement for critical processes.
To learn more, visit https://www.rfxcel.com/rfxcel-traceability-software-release-6-0/

“rTS 6.0’s cutting-edge architecture makes fast, easy data insight a reality for all customers. We’re incredibly proud of the work the rfxcel team has done to deliver this game-changing serialization and compliance technology, and most importantly, make it a seamless upgrade for our customers. rfxcel brings increased visibility and flexibility to supply chain traceability and product serialization, making data more assessable than ever before.” – Atul Mohidekar Chief Technology Officer at rfxcel.

The rTS 6.0 platform is designed to simplify and accelerate how customers can meet their compliance, serialization and track and trace requirements. By leveraging a new architecture and optimization techniques, customers can be confident that their investment will meet their current obligations and scale to meet their future needs.

To learn more about how we can help you with your needs for compliance, serialization, and track and trace, please visit us at www.rfxcel.com.

 

For more information, contact us:

Herb Wong, VP Marketing

hwong@rfxcel.com

rfxcel.com

 

About rfxcel:

rfxcel is the leading provider of SaaS-based track and trace solutions. Their platform enables companies to protect patients, comply with regulatory mandates, and gain visibility into their supply chain. rfxcel’s relentless commitment to customer success and continuous innovation ensures that companies can meet today’s requirements and tomorrow’s challenges.

Technically Certified Connection Provider for EMVO

San Ramon, December 21, 2017 – rfxcel, a global Track & Trace company, has been confirmed as a EMVO Technically Certified Connection Provider. This provides the ability for pharmaceutical manufacturers to use rfxcel to connect their product master data to the European Hub, and to meet EU Falsified Medicine Directive (FMD) serialization and compliance requirements.

The European Medicines Verification System (EMVS) is a pan-European system operated by EMVO, to enable medicines to be verified at the point of dispensing. Under the terms of the EU Falsified Medicines Directive (FMD) from 9th February 2019, Marketing Authorization Holders within the FMD’s jurisdiction will be required to upload their product serialization data via the EMVS European Hub.

As a Technically Certified Connection Provider, rfxcel will enable Marketing Authorization Holders to capture and report their serialized data and related transactions to the European Hub via a validated, secure and cost-effective solution.

“This marks another major milestone for rfxcel as we continue to grow to meet the traceability and regulatory needs of the pharmaceutical industry in Europe.  We are excited to offer the most flexible and feature-rich solution to aid EMVO in its mission to protect the drug supply chain”, said Glenn Abood, CEO of rfxcel.

As the pioneer and leader in traceability solutions for the Life Sciences industry, rfxcel provides its customers with a robust and sophisticated platform with a low total-cost-of-ownership. The EMVO certification – combined with a recent $30M growth capital infusion, the acquisition of Frequentz assets, and important key hires in Europe – widens the Company’s lead as the most versatile player in the industry.

 

About rfxcel:

rfxcel is the leading provider of SaaS-based track and trace solutions. Their platform enables companies to protect patients, comply with regulatory mandates, and gain visibility into their supply chain. rfxcel’s relentless commitment to customer success and continuous innovation ensures that companies can meet today’s requirements and tomorrow’s challenges.

 

Contact information:

Herb Wong, VP of Marketing

hwong@rfxcel.com

www.rfxcel.com

Leaders in Track and Trace Join rfxcel Executive Team

As part of rfxcel’s continued commitment to serve its global customers, rfxcel is pleased to announce that key leaders in track and trace join rfxcel Executive Team to drive global growth.

Jim Moore joins rfxcel as Senior VP of Corporate Development and GM of International Operations.

Jim has been an advisor to rfxcel, led the Company’s recent $30M capital raise with Kayne Partners, facilitated rfxcel’s entry into new geographies such as India and Europe, and completed the asset purchase from Frequentz. Jim has a unique track record of success in enterprise technology operations, analysis and investment banking.

“I am excited to bring my experience to drive international growth, partnerships, and M&A to further rfxcel’s mission to combat counterfeit pharmaceuticals, food and other products critical to the consumer”, said Moore.

“Jim has been invaluable in helping us formulate our capitalization and growth strategies and we are very pleased to have his experience and creativity added to our senior management team”, said Glenn Abood, CEO.

Simon Manley joins rfxcel as its new Commercial Director for Europe.

Simon will be responsible for driving rfxcel’s overall sales strategy and offerings to both existing and new clients in Europe. Simon will oversee marketing, strategic business partnerships and sales for Europe.

Simon joins from Oracle, where he was Sales Director for EMEA in the Health Sciences Global Business Unit, resulting in a huge expansion in sales growth across Europe, Middle East and Africa. Prior to this he was Vice President of Sales and Marketing at McKesson, a pharmaceutical distributor and the 5th highest revenue generating company in the US.

Commenting on the new appointment, Jim Moore said: “Simon brings relevant know-how to rfxcel and will be an asset to the management team. His knowledge of sales, customer satisfaction and international experience will be invaluable as we look to grow our presence in Europe.”

Manley commented: “I look forward to expanding rfxcel’s business both in Europe and globally. rfxcel’s commitment to customer success and continuous innovation ensures that customers meet their requirements and protect those who depend on them.  I am proud to be working with a team that can deliver all of this”

As the pioneer and leader in track and trace solutions for the Life Sciences market, rfxcel provides solutions to ensure customer success and secure their supply chain.

 

For more information contact us:

Herb Wong, VP Marketing

hwong@rfxcel.com

rfxcel.com

 

About rfxcel:

As the pioneer and leader in track and trace solutions for the Life Sciences, rfxcel provides solutions to improve the safety, quality, and security throughout the Life Sciences supply chain.

rfxcel Acquires Frequentz Assets

rfxcel, the world’s leader in supply chain track and trace for the Pharmaceutical industry is pleased to announce the acquisition of assets from Frequentz, Inc., a leading player in life science and food traceability. This combination will bring new benefits to prospective and existing customers.

Under this agreement, rfxcel acquires Frequentz technology, patents, contracts and personnel.  This acquisition enables rfxcel to retain some of the industry’s most talented and knowledgeable personnel in serialization and traceability solutions. rfxcel will assume customer relationships and support for all Frequentz customers in the Pharmaceutical and Food industries.

This combined organization will extend rfxcel’s customer list to include some of the largest manufacturers and wholesalers in the world. This positions rfxcel as the largest independent traceability provider for the Life Sciences and Food industries offering full data and system validation.

“We are thrilled to be joining the leader in this space and to bring food traceability to the global market. We have spent many years developing this market and the combined entity will be the best positioned player in this fast growing industry”, said Charlie Sweat, founder of Frequentz.

“This acquisition will add to our expanding footprint in the global Life Sciences space and launch us into the Food industry. We are very pleased to now offer the world’s most sophisticated product Serialization and Traceability platform to the food industry to ensure consumer safety and enhance supply chain visibility” according to Glenn Abood, CEO of rfxcel.

The acquisition of the Frequentz assets is effective on December 5th, 2017.  Key resources from Frequentz will be transitioned to rfxcel as part of this effort to ensure a seamless experience for all customers.

As the pioneer and leader in track and trace solutions for the Life Sciences industry, rfxcel has developed a highly scalable platform for supply chain visibility, anti-counterfeiting and compliance. This acquisition combined with a recent $30M growth capital infusion and important key hires widens the Company’s lead as the strongest player in the industry.

 

For more information contact us:

Herb Wong, VP of Marketing

hwong@rfxcel.com

www.rfxcel.com

Patient Safety Through Traceability

Global pharmaceutical safety
through smart serialization and open collaboration

 

Medications – we all use them, but how can we be sure they are authentic and safe? 10-15% of the world’s drug supply is counterfeit. Criminals mislabel drugs to scam consumers, selling the fake drug as authentic. The pharmaceutical industry loses hundreds of billions in profit. Hundreds of thousands of patients are at risk of losing their lives every year.

 

The need for pharmaceutical companies to have absolute and accurate visibility of their supply chains is imperative. Global governments are demanding complete visibility into a drug’s journey from manufacturer to patient. The industry is shifting from a simple buyer-seller model to a more collaborative model. This is only possible through a Platform that is interoperable throughout the entire supply chain.

 

“This collaborative model supports the pharmaceutical industry’s need for companies to view each other as allies. rfxcel is committed to open collaboration that works with all partners, governments, and standard bodies such as GS1 and HDA. It is important to enable effective interoperability and not pursue a closed network that drives proprietary standards. By supporting the open exchange of information, companies do not have to worry about future integrations needs. Instead, companies can focus on meeting the needs of their customers and keeping their products safe.”
– Herb Wong, VP of Product Management at rfxcel.

 

rfxcel offers a global traceability solution which enables the entire pharmaceutical supply chain to track and trace products. rfxcel Traceability System can offer traceability from the raw-material supplier to the dispenser, delivering the final product safely to the end user. With over fourteen years in the pharmaceutical supply chain business, rfxcel knows that true visibility is only possible by integrating and processing data thoroughly between manufacturers, distributors, packagers, clinics and pharmacies. rfxcel works to ensure data is valid.

 

“With each step in the process, we run over sixty data verifications to reduce bad data entering the supply chain. We continuously put best data integration practices into effect, improving accuracy and visibility of the supply chain. Each shipment is assigned a serial number. At every handoff the receiving party scans that number. rfxcel instantly ascertains the data, providing a digital report with data points about the product and its history. We aggregate the date in a relationship hierarchy, so recipients gain complete visibility into every pallet, case and bottle. This process ensures trading partners feel confident that medications are authentic and safe.”
– Herb Wong, VP of Product Management at rfxcel.

 

Today, the rfxcel Traceability Platform provides a global solution to eliminate threats such as counterfeiting, product diversion, and theft. It is a flexible and reliable system that reduces the cost and difficulty of implementing traceability technology. rfxcel has strong experience and knowledge of industry standards, and has partnerships with regulatory agencies. This provides the solution that manufacturers and pharmaceutical companies need.

 

About rfxcel:

rfxcel is the leading provider of SaaS-based track and trace solutions. Their solution enables companies to protect patients and meet their compliance needs, while getting insights and visibility into their supply chain. Their relentless commitment to customer success and continuous innovation ensures that companies meet their requirements and protect those who depend on them.

rfxcel Drives EU Expansion with Industry Experts

rfxcel will expand its capability to enable Life Sciences companies to meet serialization and regulatory compliance needs in the European territories. The company, which already has a presence in 4 continents, announced on Monday that it will accelerate its global expansion to operate throughout Europe.

rfxcel is staffed with industry leaders that understand the importance of data accuracy, global compliance and serialization processing. This approach has made rfxcel the leader in traceability and serialization.

Mark Davison is a leading expert and published author in Serialization and EU Pharma technologies. He will head up the rfxcel team in the European territories as the Senior Director of Operations for Europe.

“Data accuracy matters in serialization. Unfortunately, experience tells us that most solution providers only push data and events through without verifying if it meets regulations, or even check for duplication in generating serial numbers. At rfxcel we believe that customers need to think of accurate data processing from the beginning and we provide a more active data validation approach as standard.” – Mark Davison, Senior Director of Operations Europe.

rfxcel will be hosting a discussion at the Pharma TrackTS! 2017 conference in Berlin September 28th and 29th. Mark Davison and rfxcel’s Chief Strategy Officer, Jack Tarkoff, will be speaking about the importance of data validation and its effects on supply chain management.  

As the pioneer and leader in track and trace solutions for the Life Sciences, rfxcel provides solutions to ensure customer success and secure their business. rfxcel is excited to help fulfill the serialization and compliance needs within Europe.

For more information contact us:
Herb Wong, VP Marketing
hwong@rfxcel.com
rfxcel.com

RFXCEL RAISES $30 MILLION IN SERIES B FINANCING.

San Ramon, CA – August 3, 2017 – rfXcel, the leader in Track and Trace and regulatory compliance solutions, today announces it has raised $30 million in a round of funding led by Kayne Partners. Kayne Partners is the growth private equity group of Kayne Anderson Capital Advisors, L.P., an alternative investment firm managing over $25 billion in assets.

 

rfXcel plans to use this investment to accelerate the delivery of innovative supply chain solutions; increase resources to extend its successful Internet of Things (“IoT”) partnership with Verizon; and expand its global geographical presence in the Americas, Europe, Middle East and Asia Pacific. Founded in 2003, rfXcel has been providing mission-critical solutions to life sciences customers longer than any provider in this space. Because of its tenure and commitment to innovation, rfXcel offers the most feature-rich solution and flexible platform in the market.

 

rfXcel offers customers a long-term strategic solution to gain insight and visibility into their supply chains,” said Leon Chen, Managing Director of Kayne Partners, who will join rfXcel’s board of directors as part of this financing. “rfXcel has developed a track record of building great technology and partnering with customers in life sciences and other industries to build strong business relationships and solve complex challenges.”

 

We are excited to team with Kayne Partners,” said Glenn Abood, Co-Founder and CEO of rfXcel. “rfXcel has the longest track record in meeting the supply chain visibility and regulatory needs in the life sciences industry. This partnership allows rfXcel to accelerate its market growth and extend its leading edge technology. With the accelerated changes in technology and shifting market needs, rfXcel will continue to lead the industry with its technology platform and laser focus on customer success. Our mission is to protect patients and combat the illegal counterfeit pharmaceutical market and this capital provides us with the means to broaden our reach in this battle.”

 

About rfXcel:
rfXcel is the leading provider of SaaS based track and trace solutions that enables customers to protect patients and meet their compliance needs while getting insights and visibility into their supply chain. Its relentless commitment to customer success and continuous innovation ensures that customers meet their requirements and protect those who depend on them.

 

About Kayne Partners

Kayne Partners is a leading provider of capital and connections to rapidly growing companies in North America. Since its inception more than a decade ago, it has invested over $600 million in platform investments and add-on acquisitions. Kayne Partners seeks to partner with driven entrepreneurs as a non-control minority investor and provide transformative capital to these high growth companies. Kayne Partners is the growth private equity group of Kayne Anderson Capital Advisors, L.P.

For more information, visit www.kaynepartners.com

 

About Kayne Anderson Capital Advisors, L.P.

Kayne Anderson Capital Advisors, L.P., founded in 1984, is a leading alternative investment management firm focused on niche investing in upstream oil and gas companies, energy and infrastructure, specialized real estate, growth equity and both private credit and diversified liquid credit. Kayne Anderson manages over $25 billion in assets and employs over 300 professionals in eight offices across the U.S.

Kayne Anderson is headquartered in Los Angeles with offices in Houston, New York City, Chicago, Denver, Dallas, Atlanta and Boca Raton.

For more information, visit www.kaynecapital.com

 

Contacts

Kayne Partners:
Leon Chen, Managing Director
310.282.2834 or lchen@kaynecapital.com

rfXcel:
Herb Wong, Head of Marketing
925.791.3235 or hwong@rfxcel.com